Table 2 The 17-gene RFRS signature
From: A robust prognostic signature for hormone-positive node-negative breast cancer
Primary predictor | Alternate 1 | Alternate 2 | |||
|---|---|---|---|---|---|
CCNB2 | 0.785 | MELK | 0.739 | GINS1 | 0.476 |
TOP2A | 0.590 | MCM2 | 0.428 | CDK1 | 0.379 |
RACGAP1 | 0.588 | LSM1 | 0.139 | SCD | 0.125 |
CKS2 | 0.515 | NUSAP1 | 0.491 | ZWINT | 0.272 |
AURKA | 0.508 | PRC1 | 0.499 | CENPF | 0.306 |
FEN1 | 0.403 | FADD | 0.313 | SMC4 | 0.170 |
EBP | 0.341 | RFC4 | 0.264 | NCAPG | 0.234 |
TXNIP | 0.292 | N/A | N/A | N/A | N/A |
SYNE2 | 0.270 | SCARB2 | 0.225 | PDLIM5 | 0.167 |
DICER1 | 0.209 | CALD1 | 0.129 | SOX9 | 0.125 |
AP1AR | 0.201 | PBX2 | 0.134 | WASL | 0.126 |
NUP107 | 0.197 | FAM38A | 0.165 | PLIN2 | 0.110 |
APOC1 | 0.176 | APOE | 0.121 | N/A | N/A |
DTX4 | 0.164 | AQP1 | 0.141 | LMO4 | 0.120 |
FMOD | 0.154 | RGS5 | 0.120 | PIK3R1 | 0.103 |
MAPKAPK2 | 0.151 | MTUS1 | 0.136 | DHX9 | 0.136 |
SUPT4H1 | 0.111 | PHB | 0.106 | CD44 | 0.105 |